Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01407952 · ClinicalTrials.gov registry record · NA
Hydrogel Endovascular Aneurysm Treatment Trial
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT01407952 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 600 participants.
The verdict
NCT01407952, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
This research study is being done to test the effectiveness of a new generation FDA approved device for treating aneurysms compared to the current standard device for endovascular aneurysm treatment which is bare platinum coils. Endovascular procedures are a form of minimally invasive surgery, which is performed on blood vessels. The technique involves the introduction of a catheter which is a long, thin, flexible, hollow plastic tube through the skin into a large blood vessel. Typically the chosen blood vessel is the femoral artery found near the groin. The catheter is then maneuvered through the body to the location of the aneurysm in the brain using image guidance. Coils are delivered into the aneurysm through the catheters. Once the coils are delivered in the aneurysm, they are detached from the catheter. This is repeated until enough coils fill the aneurysm, blocking the blood flow to the aneurysm. The body responds by forming blood clots around the coil(s), which helps block the flow of blood into the aneurysm and keeps the vessel from rupturing or leaking. This study will compare the study device to the standard bare platinum coil to see which is better at preventing future rupturing or leaking. The study device is called the HydroCoil Embolization System and this study is a post-market clinical trial. About 600 subjects from multiple institutions will take part in this study.
Interventions
- DEVICE HydroCoil Embolic System
- DEVICE Control (bare platinum coils)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2012-04 |
| Est. Completion | 2018-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01407952
The ClinicalTrials.gov registry entry for NCT01407952 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HydroCoil Embolic System is the first listed.
NCT01407952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01407952 about?
NCT01407952 is a clinical study titled "Hydrogel Endovascular Aneurysm Treatment Trial". This research study is being done to test the effectiveness of a new generation FDA approved device for treating aneurysms compared to the current standard device for endovascular aneurysm treatment which is bare platinum coils. Endovascular procedures are a form of minimally invasive surgery, which...
What is the current status of trial NCT01407952?
This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2012-04. Estimated completion is 2018-03.
What interventions are being tested in trial NCT01407952?
The interventions under investigation include: HydroCoil Embolic System (DEVICE), Control (bare platinum coils) (DEVICE).
Who is sponsoring clinical trial NCT01407952?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.